Blood Health 2020
-
Genomics helps unravel blood cancer
Genomics is hailed as one of the most exciting medical developments in recent years – but what will it mean for blood cancer patients? “We’re only looking at the tip of the iceberg of what genomics can do in terms of haematological cancers,” says Dr Daniel Hobson, Clinician Scientist Fellow at the University of Cambridge....
-
s Sponsored
Gene therapy could be a “game changer” in haemophilia
After a 20-year seesaw of rising expectations and crushing failures, gene therapy is demonstrating its transformative potential in haemophilia A and B treatment. Gene therapy has long been ‘the Holy Grail’ in haemophilia treatment, and after years of raised expectations and dashed hopes, the approach is finally starting to bear fruit. Blood disorders are characterised...
-
s Sponsored
How the pandemic has increased focus on innovation
Patients have had restricted access to medical care and innovation during COVID-19. Stakeholder collaboration is vital to ensure this doesn’t become a long-term setback. The full impact of COVID-19 on UK health services may not be fully understood for some time – but it’s already clear that the effects go beyond front line services. With...
-
s Sponsored
Transforming sickle cell disease services to offer fresh hope
Sickle cell disease is a painful, unpredictable condition that severely impacts on health and quality of life – but advances in treatments and care delivery are providing new hope. Recent advances could transform the management of sickle cell disease (SCD), an inherited blood disorder with a high toll on physical and psychological health. SCD, which...
-
Haemophilia: treatment advances and hope
One of the most common bleeding inherited disorders is haemophilia. Haemophilia A occurs in around one in 5,000 male births and haemophilia B is one in 25,000 live male births. Haemophilia A and B are clinically similar. Both are X-linked recessive disorders, occurring by mutations in the gene for blood clotting factors. The severity...
-
Why myeloma is so difficult to diagnose
“The blood cancer, myeloma, is one of the most difficult cancers to diagnose, with more than half of patients having to wait more than five months for the correct diagnosis,” says Myeloma UK Chief Executive, Laura Kerby. “One of the main challenges is for the GP to suspect that their patient may have myeloma. It...
-
Could CAR-T therapy be used more widely?
CAR-T therapy is one of the most exciting advances in cancer treatment in recent years, potentially providing a cure when all other drugs have failed. But, currently, its use is limited to a small group of patients Only six children with acute lymphoblastic leukaemia (ALL) and 75 adults with diffuse large B-cell lymphoma (DLBCL) were...
-
The impact of COVID-19 on people with blood cancer
The COVID-19 pandemic has affected everyone in the UK, but people with blood cancer have been particularly badly hit. At the beginning of the COVID-19 crisis, 200,000 cancer patients in England received a letter from the NHS, asking them to shield in their homes as they were most at risk. Of those 200,000 people, 115,000...
Health Awareness
